Advancements in medical technology and pharmaceuticals have revolutionized healthcare, leading to improved diagnosis and treatment of numerous diseases. Among these, cancer remains a key focus area, with germ cell tumors (GCTs), though rare, gaining increasing prominence. The GCT market is projected to grow significantly, propelled by rising prevalence, evolving treatment innovations, and a...